Shockwave Medical stock trades without a current quote

Published on 09/22/2026 at 16:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Shockwave Medical stock remains tied to its latest reported figures from 2026. The company operates in intravascular lithotripsy and carries ISIN US8130281086.

SWAV, US8130281086, Illustration mit AI erstellt.

Shockwave Medical stock is identified by ISIN US8130281086 and trades under the SWAV symbol on Nasdaq. The company develops intravascular lithotripsy systems for treating vascular disease, giving its revenue profile a direct link to procedure volumes and hospital adoption.

Medical device exposure remains central

Shockwave Medical's business is concentrated in a specialized medical-device category rather than broad pharmaceutical demand. Its products use sound waves to modify calcified vascular lesions, a treatment approach that connects commercial performance with physician use, reimbursement and procedure growth.

The latest available company context is reported in 2026, while the shares remain classified as a US-listed healthcare security. The operating indicators that matter most are revenue, earnings, margins and procedure adoption because each can influence how the market values the company's growth profile.

Reporting period defines the valuation picture

For investors, the reporting period is essential when comparing Shockwave Medical with other medical-device companies. A quarterly revenue figure, an earnings-per-share result or a margin percentage is meaningful only when paired with the relevant quarter or fiscal year, because publication dates do not change the period in which the business generated the result.

Shockwave Medical stock therefore remains a company-specific healthcare position whose valuation depends on measurable operating progress rather than on a broad sector label. The combination of a specialized product portfolio and Nasdaq listing gives the security a distinct market profile, while procedure growth and execution remain the central operating reference points.

Nasdaq listing anchors the stock profile

Shockwave Medical stock is associated with the Nasdaq venue, the SWAV ticker and the healthcare sector. The security's ISIN is US8130281086, and these identifiers distinguish the company from similarly named medical-device issuers and from unrelated securities using other tickers.

On September 22, 2026, the stock profile is defined by its US listing, its medical-device exposure and the need to assess the latest period-specific operating data alongside market valuation. The company name, ticker and ISIN provide the fixed reference frame for that assessment.